Latest Publications

Share:

Hospira, Inc. v. Fresenius Kabi USA, LLC (Fed. Cir. 2020)

It seems that memes can be as compelling in the law as in social media, and the meme of the moment in patent law is inherency, particularly as applied to obviousness determinations (see, for example, Persion Pharmaceuticals...more

U.S. Supreme Court on Eligibility: Nothing to See Here, Move Along

The Supreme Court entered orders denying certiorari in all five cases having petitions on subject matter eligibility, including Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC; Hikma Pharmaceuticals USA Inc. v....more

The "Ending the Diagnostic Odyssey Act of 2019"

On January 6, 2020, a bi-partisan coalition of Senators, including Senator Collins (R-ME), Doug Jones (D-AL), Martha McSally (R-AZ), and Bob Menendez (D-NJ), introduced the "Ending the Diagnostic Odyssey Act of 2019" to...more

Amgen Inc. v. Amneal Pharmaceuticals LLC (Fed. Cir. 2020)

Transitional terms in patent law (conventionally, "comprising," "consisting of," and the more arcane "consisting essentially of") have their own provenance and meaning, denoting limitations that are "open" (comprising) or...more

Persion Pharmaceuticals LLC v.  Alvogen Malta Operations Ltd. (Fed. Cir. 2019)

Last week, the Federal Circuit affirmed a District Court decision (by Circuit Judge Bryson, sitting by designation) in an ANDA litigation, finding obvious claims asserted for treating patients having mild to moderate hepatic...more

CRISPR Interference Update

All interferences have filings that are either kept confidential or are entirely procedural in nature.  While there is little substantive to discuss, acknowledging them serves the purpose of keeping track of the proceedings;...more

Representative Danny K. Davis Introduces ''Inventor Rights Act"

Last year, Judge Illston gifted patentees with a proverbial lump of coal with her decision in Illumina, Inc. v. Ariosa Diagnostics, Inc. by invalidating on summary judgment claims directed to methods for isolating cell-free...more

Syngenta Crop Protection, LLC v. Willowood, LLC (Fed. Cir. 2019)

The Federal Circuit had the opportunity to interpret the extent to which the provisions of 35 U.S.C. § 271(g) require the practice of the patented method that produces a product whose importation imposes infringement...more

Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)

The Federal Circuit has grappled with, divisively in some instances, the extent to which the safe harbor provisions of 35 U.S.C. § 271(e)(1) extend to activities not strictly for obtaining regulatory approval, such as...more

Broad Files Reply Brief to Berkeley's Opposition to Substantive Motion No. 1

In early November, Senior Party the Broad Institute (along with Harvard University and the Massachusetts Institute of Technology) filed their response to Junior Party the University of California/Berkeley, the University of...more

Berkeley Files Responsive Motion to Broad's Substantive Motion No. 2 in Interference

As previously discussed, Senior Party The Broad Institute (joined by Harvard University and MIT) on October 14th filed Substantive Motion No 2 (to substitute the count) in the current interference over CRISPR technology (No....more

Berkeley Files Substantive Motion No. 2 to be Accorded Benefit to Earlier Priority Application in Interference

On October 14th, Junior Party the University of California, Berkeley; the University of Vienna; and Emmanuelle Charpentier; collectively, "CVC") filed its Substantive Motion No. 1 to be awarded priority benefit to their...more

Pharma Tech Solutions, Inc. v. Lifescan, Inc. (Fed. Cir. 2019)

"Everything you say can be held against you" is a trope in crime shows from the U.S., Australia, New Zealand, the UK, and Ireland (stated in various ways), and a recent decision by the Federal Circuit regarding preclusion of...more

CRISPR Housekeeping

Part of every interference are a variety of housekeeping matters which, while not dispositive, are important to recognize for their effects (or potential effects) on the proceedings.  Some are simple matters:  for example, on...more

CRISPR Motions Day at the PTAB: Broad Files Its Substantive Motion No. 4

On October 14th, Senior Party the Broad Institute (joined by Harvard University and MIT) filed several authorized motions in Interference No. 106,115, including Substantive Motion No. 2 and No. 3, against Junior Party the...more

CRISPR Motions Day at the PTAB: Broad Files Its Substantive Motion No. 3

On October 14th, Senior Party the Broad Institute (joined by Harvard University and MIT) filed several authorized motions, including Substantive Motion No. 3 (to designate claims as not corresponding to the count), against...more

CRISPR Motions Day at the PTAB: Broad Files Its Substantive Motion No. 2

October 14th was a busy day at the Patent Trial and Appeal Board (PTAB) for the current interference over CRISPR technology (No. 106,115).  The Junior Party (the University of California, Berkeley; the University of Vienna;...more

Correlation Found Between Left-Handedness and Genetic Markers Associated with Neurological Disease

Left-handedness is a uniquely human trait, with 90% human populations globally being right-handed since the Paleolithic (extending from 3.3 million years ago to the end of the Pleistocene).  A feature of motor control, the...more

11/14/2019  /  DNA , Human Genes , Life Sciences

BRCA2 Gene Mutations Associated with Risk of Childhood Lymphoma

The BRCA2 gene is one member of a pair of genes that changed the patent landscape several years ago, when the Supreme Court ruled that "mere" isolation was insufficient to render genomic embodiments thereof patent eligible,...more

Berkeley Files Opposition to Broad's Substantive Motion No. 1 in Interference

On October 18th, Junior Party (the University of California, Berkeley; the University of Vienna; and Emmanuelle Charpentier (collectively, "CVC") filed its authorized opposition to Substantive Motion No. 1 from Senior Party...more

GlobalData Discloses Top 20 Pharma Rankings

As reported in John Carrol's EndPoint News early last month, GlobalData has published a list of the Top 20 Pharmaceutical Companies by market cap as of March 31, 2019.  ...more

Genetic Basis for Resistance to Toxic Compounds in Monarch Butterflies Elucidated

One of the wonders and satisfactions of modern science has been the elucidation (usually based in genetics) of the wonders of nature that have been famously observed but not explained until the proper tools (again, usually...more

Board Denies CVC Motion to Seal Priority Statement

On September 11th, Junior Party (Regents of the University of California, University of Vienna, and Emmanuelle Charpentier, collectively "CVC") in Interference No. 106,115 with The Broad Institute et al. filed a motion to...more

Federal Circuit Holds APJs Are Principal Officers

On October 31, 2019, in Arthrex, Inc. v. Smith & Nephew, Inc., a three-judge panel of the Federal Circuit held that the way the U.S. Patent and Trademark Office has appointed administrative patent judges at the Patent Trial...more

Idenix Pharmaceuticals LLC v. Gilead Sciences Inc. (Fed. Cir. 2019)

Section 112 of the Patent Act as codified, entitled "Specification" in the statute, specifies the amount of disclosure required to support a patent claim (among other requirements).  Section 112(a) contains three...more

1,002 Results
 / 
View per page
Page: of 41

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide